Research Articleposted Nov 09, 2022
Effectiveness and toxicity of re-irradiation after breast conserving surgery for recurrent or new primary breast cancer: a multi-institutional study
Camille Hardy Abeloos, Julie Xiao, Cheongeun Oh, David Barbee, Carmen A Perez, Ruth Oratz, Freya Schnabel, and 6 more authors
Under Review
at
Research Articleposted Nov 07, 2022
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
Kenichi Watanabe, Naoki Niikura, Yuichiro Kikawa, Mari Oba, Kokoro Kobayashi, Hiroshi Tada, Shinji Ozaki, and 10 more authors
Under Review
at
Research Articleposted Nov 07, 2022
CEM and MR Radiomics-based Biomarkers to Predict Immunohistochemistry Breast Cancer Subtypes: A comparative study
Ashif Iquebal, Siqiong Zhou, Nicholaus Pfeiffer, Sara Ranjbar, Imon Banerjee, Kristin Swanson, Felipe Batalini, and 4 more authors
Under Review
at
Research Articleposted Nov 02, 2022
Neighborhood and Racial Influences on Triple Negative Breast Cancer: Evidence from Northeast Ohio
Kirsten Y Eom, Kristen A Berg, Natalie E Joseph, Kristen Runner, Yasir Tarabichi, Amer Khiyami, Adam T Perzynski, and 1 more authors
Under Review
at
Research Articleupdated Nov 02, 2022
Longitudinal associations among physical activity and sitting with endocrine symptoms and quality of life in breast cancer survivors: A latent growth curve analysis
Alexander R Lucas, Youngdeok Kim, Autumn Lanoye, R. Lee Franco, Arnethea Sutton, Jessica G LaRose, Masey Ross, and 1 more authors
Under Review
at
Research Articleposted Oct 28, 2022
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution
Jean-Louis LACAZE, Gauthier Glemarec, Ciprian Chira, Mony Ung, Carole Massabeau, Niels Monselet, Thibaut Cassou-Mounat, and 7 more authors
Under Review
at
Research Articleposted Oct 26, 2022
Prognostic factors and clinical outcomes of breast cancer patients with disease progression during neoadjuvant systemic therapy
Yun-Xiao Ling, Yi-Fan Xie, Huai-Liang Wu, Xiao-Fang Wang, Jin-Li Ma, Lei Fan, Guang-Yu Liu
Under Review
at
Research Articleposted Oct 26, 2022
A Phase I/II Study of Preoperative Letrozole, Everolimus, and Carotuximab in Stage 2 and 3 Hormone Receptor-positive and Her2-negative Breast Cancer.
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, and 4 more authors
Under Review
at
Research Articleposted Oct 25, 2022
Surviving the COVID-19 Pandemic: Navigating the Recovery of Breast Imaging Services in a Safety-Net Hospital
Jessica H. Porembka, Stephen J. Seiler, Berat Bersu Ozcan, W. Phil Evans, Jasmin Tiro, Basak E. Dogan
Under Review
at
Research Articleposted Oct 19, 2022
The potential of adding mammography to HHUS and ABUS to reduce unnecessary biopsies in BI-RADS ultrasound category 4a: a multicenter hospital-based study in China
Wenhui Ren, Xuelian Zhao, Xiaowei Zhao, Huijiao Yan, Shangying Hu, Youlin Qiao, Zhijian Xu, and 1 more authors
Under Review
at